DXCM logo

DXCM DexCom, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$82.27
+0.66 (+0.81%)

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes ma…

Market Cap: $30.68Bwww.dexcom.com

Price

No data yet.

Social Signal Score

64
5d
70
1 mentions
—
30d
65
16 mentions
—
60d
61
25 mentions
—
90d
62
30 mentions
—
news: 22 · marketaux: 2 · rss: 6

Analyst Ratings

53 analysts
Buyconsensus
Strong Buy 1Buy 43Hold 8Sell 1Strong Sell 0
Avg price target$97.85+18.9%
Low $86Median $96High $115
Current Consensus

Revenue

$1.34B+685.34%
$142.30M$543.03M$943.77M$1.34B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.06
$2.01–$2.09
17 analysts
FY2026
$2.70+31% YoY
$2.47–$2.77
15 analysts
FY2027
$3.14+16% YoY
$2.82–$3.28
16 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jacob Steven Leach
Sector
Healthcare
Industry
Medical - Devices
Employees
11,050
Beta
1.44
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
7.45
www.dexcom.com